The ROE as of November 2024 (TTM) for H-CYTE, Inc. (HCYT) is 60.71%

According to H-CYTE, Inc.’s latest financial reports and current stock price. The company's current ROE is 60.71%. This represents a change of 158.35% compared to the average of 23.50% of the last 4 quarters.

H-CYTE, Inc. (HCYT) Historical ROE (quarterly & annually)

How has HCYT ROE performed in the past?

The mean historical ROE of H-CYTE, Inc. over the last ten years is 523.35%. The current 60.71% ROE has changed -88.40% with respect to the historical average. Over the past ten years (40 quarters), HCYT's ROE was at its highest in in the March 2018 quarter at 742.39%. The ROE was at its lowest in in the June 2016 quarter at -727.54%.

H-CYTE, Inc. (HCYT) ROE by Quarter and Year

Discovering the peaks and valleys of H-CYTE, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

H-CYTE, Inc. (HCYT) Average ROE

How has HCYT ROE performed in the past?

The current ROE of H-CYTE, Inc. (HCYT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

H-CYTE, Inc. (HCYT) ROE vs. Peers

How is HCYT’s ROE compared to its peers?

H-CYTE, Inc.’s ROE is greater than Algernon Pharmaceuticals Inc. (-213.50%), less than Adynxx, Inc. (0%), greater than Ascletis Pharma Inc. (0%), greater than BioCardia, Inc. (-0.89%), less than Genelux Corporation (526.79%), greater than Comera Life Sciences Holdings, Inc. (-110.28%), less than Dyadic International, Inc. (67.46%), greater than Cingulate Inc. (-145.95%), less than Monopar Therapeutics Inc. (11.47%), greater than Wesana Health Holdings Inc. (-110.60%), less than BioVaxys Technology Corp. (242.19%), less than GH Research PLC (322.77%), greater than AXIM Biotechnologies, Inc. (-16.39%), less than Aura Biosciences, Inc. (54.15%), greater than Axcella Health Inc. (-41.49%), greater than Bavarian Nordic A/S (-3582.11%), less than Antibe Therapeutics Inc. (7.02%), greater than null (-49.77%),

Build a custom stock screener for H-CYTE, Inc. (HCYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like H-CYTE, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

H-CYTE, Inc. (HCYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like H-CYTE, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.